Head of GloballRegulatory Compliance
Cytiva
Angela Johnson, PhD, RAC is the Executive Head of Global Regulatory compliance for Cytiva and lecturer on regulatory strategy at Northeastern University. She has led two venture-backed biotech regulatory start-up teams to successful IPO and held leadership roles at IQVIA, GE Healthcare, and APAC consulting firms in drug development, and is an active member of the Regulatory Affairs Professionals Society (RAPS) and regulatory board member of the American Society of Cell & Gene Therapy (ASGCT), with more than 30 publications on regulatory and drug development. She has presented internationally on clinical trial design, regulatory strategy, market access, and manufacturing & validation for complex biologics and drug delivery systems, and has helped bring commercial mAbs, biosimilar, and gene therapies across the finish line to global approval in her roles as a CRO and CMO leader. She is also a pioneering executive director of Cytiva’s Regulatory Science & Intelligence team, with over 90 regulatory staff enabling more than a thousand regulatory meetings, filings, and registrations/certifications each year across a range of therapeutic and technology areas.
Wednesday, September 18, 2024
2:15 PM – 3:15 PM PDT